Enlaza Therapeutics
Developer of covalent protein therapeutics intended to deliver efficacious and safer treatments. The company offers a novel synthetic biology platform that uses covalent bonds to lock onto a target pr...
Valuation
$295M
Market implied
Share Price
N/A
Total Raised
$176M
Last Round
N/A